FierceBiotech 25 nov. 2025 <a href="https://www.fiercebiotech.com/biotech/how-healthy-exchange-ideas-rfk-jr-kicked-fdas-gene-therapy-push" hreflang="en">How a 'healthy exchange of ideas' with RFK Jr. kick-started FDA's gene therapy push</a> #Tim Hunt #Human Services
FierceBiotech 25 nov. 2025 <a href="https://www.fiercebiotech.com/medtech/ge-healthcare-acquire-imaging-software-provider-intelerad-23b" hreflang="en">GE HealthCare to acquire imaging software provider Intelerad for $2.3B</a> #cardiology practices #clinical trials
FierceBiotech 25 nov. 2025 <a href="https://www.fiercebiotech.com/biotech/fierce-biotech-layoff-tracker-2025" hreflang="en">Fierce Biotech Layoff Tracker 2025: Applied Tx lays off 46% of staff; Ensoma makes cuts</a> #Fierce Biotech #Layoff Tracker
FierceBiotech 25 nov. 2025 <a href="https://www.fiercebiotech.com/biotech/letter-makary-biotech-ceos-push-fda-stability-and-say-volatility-threatens-us-innovation" hreflang="en">In letter to Makary, biotech CEOs push for FDA stability and say volatility threatens US innovation</a> #Marty Makary #Director Marty
FierceBiotech 25 nov. 2025 <a href="https://www.fiercebiotech.com/biotech/contineums-jj-partnered-ms-drug-fails-improve-vision-phase-2" hreflang="en">Contineum's J&J-partnered MS drug fails to improve vision in phase 2</a> #Contineum Therapeutics’ #receptor antagonist
FierceBiotech 25 nov. 2025 <a href="https://www.fiercebiotech.com/biotech/fda-kicks-hiring-spree-and-new-communication-program-speed-sluggish-drug-reviews" hreflang="en"> FDA says it's hiring more than 1,000 new staffers, launches new comms program for review process</a> #review process #pilot communication
FierceBiotech 25 nov. 2025 <a href="https://www.fiercebiotech.com/pharma/gsks-tesaro-and-licensor-anaptysbio-lock-horns-court-over-jemperli-agreement" hreflang="en">GSK's Tesaro, AnaptysBio lock horns in court over Jemperli agreement</a> #GSK Tesaro #Jemperli agreement
FierceBiotech 25 nov. 2025 <a href="https://www.fiercebiotech.com/biotech/nurix-trims-workforce-pivotal-trial-lead-btk-degrader-kicks" hreflang="en">Nurix trims workforce as pivotal trial for lead BTK degrader kicks off</a> #Nurix Therapeutics #Nurix trims
FierceBiotech 25 nov. 2025 <a href="https://www.fiercebiotech.com/medtech/roche-inks-200m-licensing-pact-freenomes-cancer-screening-blood-tests" hreflang="en">Roche inks $200M-plus licensing pact for Freenome's cancer screening blood tests</a> #Roche inks #licensing pact
FierceBiotech 25 nov. 2025 <a href="https://www.fiercebiotech.com/biotech/chutes-ladders-gilead-abruptly-parts-ways-general-counsel" hreflang="en">Chutes & Ladders—Gilead abruptly parts ways with general counsel</a> #Deborah Telman #filing Nov.
FierceBiotech 25 nov. 2025 <a href="https://www.fiercebiotech.com/research/cdc-instructs-researchers-end-all-monkey-studies-year-end-science" hreflang="en">CDC instructs researchers to end all monkey studies by year-end: Science</a> #Science reported #CDC instructs
FierceBiotech 25 nov. 2025 <a href="https://www.fiercebiotech.com/biotech/versants-dayra-dawns-50m-biogen-pact-oral-macrocyclic-peptide-mission" hreflang="en">Versant's Dayra dawns with $50M Biogen pact, oral macrocyclic peptide mission</a> #Dayra Therapeutics #Versant Ventures
FierceBiotech 25 nov. 2025 <a href="https://www.fiercebiotech.com/biotech/jjs-5b-alzheimers-hope-fades-anti-tau-antibody-posdinemab-flops-phase-2" hreflang="en">J&J's $5B Alzheimer's hope fades as anti-tau antibody posdinemab flops in phase 2</a> #Alzheimer hope #anti-tau antibody
FierceBiotech 25 nov. 2025 <a href="https://www.fiercebiotech.com/medtech/abbott-replace-certain-freestyle-libre-3-cgms-after-incorrect-readings-and-death-reports" hreflang="en">Abbott to replace certain FreeStyle Libre 3 CGMs after incorrect readings and death reports</a> #FreeStyle Libre #million FreeStyle
FierceBiotech 25 nov. 2025 <a href="https://www.fiercebiotech.com/biotech/gilead-hatches-400m-biobucks-deal-swedish-biotechs-trex1-cancer-program" hreflang="en">Gilead hatches $400M biobucks deal for Swedish biotech’s TREX1 cancer program</a> #Sprint Bioscience #cancer program
FierceBiotech 25 nov. 2025 <a href="https://www.fiercebiotech.com/pharma/novos-shares-tumble-8-after-2-trial-misses-semaglutide-alzheimers-disease" hreflang="en">Novo shares tumble after 2 trial misses for semaglutide in Alzheimer's disease</a> #Alzheimer disease #Novo Nordisk
FierceBiotech 25 nov. 2025 <a href="https://www.fiercebiotech.com/biotech/people-are-getting-use-it-global-uncertainties-cant-dampen-upbeat-jefferies-conference" hreflang="en">'People are getting used to it': Global uncertainties can't dampen upbeat Jefferies conference</a> #Jefferies conference #Global uncertainties
FierceBiotech 25 nov. 2025 <a href="https://www.fiercebiotech.com/biotech/bayers-asundexian-cuts-stroke-risk-phase-3-reviving-hopes-fxia-class" hreflang="en">Bayer's asundexian cuts stroke risk in phase 3, reviving hopes for FXIa class</a> #Bayer asundexian #reviving hopes